Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Market Growth 2025-2031

Publication ID:

LPI04255556

Publication Date:

April 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Sodium-dependent Glucose Co-transporter 2 (SGLT2) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Sodium-dependent Glucose Co-transporter 2 (SGLT2) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sodium-dependent Glucose Co-transporter 2 (SGLT2) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sodium-dependent Glucose Co-transporter 2 (SGLT2) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sodium-dependent Glucose Co-transporter 2 (SGLT2) players cover Eli Lilly, Janssen Pharmaceuticals, Bristol Myers Squibb, Boehringer Ingelheim, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪odium-dependent Glucose Co-transporter 2 (SGLT2) Industry Forecast鈥� looks at past sales and reviews total world Sodium-dependent Glucose Co-transporter 2 (SGLT2) sales in 2024, providing a comprehensive analysis by region and market sector of projected Sodium-dependent Glucose Co-transporter 2 (SGLT2) sales for 2025 through 2031. With Sodium-dependent Glucose Co-transporter 2 (SGLT2) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium-dependent Glucose Co-transporter 2 (SGLT2) industry.
This Insight Report provides a comprehensive analysis of the global Sodium-dependent Glucose Co-transporter 2 (SGLT2) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium-dependent Glucose Co-transporter 2 (SGLT2) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Sodium-dependent Glucose Co-transporter 2 (SGLT2) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium-dependent Glucose Co-transporter 2 (SGLT2) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium-dependent Glucose Co-transporter 2 (SGLT2).
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium-dependent Glucose Co-transporter 2 (SGLT2) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Canagliflozin
Empagliflozin
Dapagliflozin
Ipragliflozin
Others
Segmentation by Application:
Hospital Pharmacy
Retail Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Janssen Pharmaceuticals
Bristol Myers Squibb
Boehringer Ingelheim
AstraZeneca
Astellas
Johnson & Johnson
Pfizer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sodium-dependent Glucose Co-transporter 2 (SGLT2) market?
What factors are driving Sodium-dependent Glucose Co-transporter 2 (SGLT2) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sodium-dependent Glucose Co-transporter 2 (SGLT2) market opportunities vary by end market size?
How does Sodium-dependent Glucose Co-transporter 2 (SGLT2) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Country/Region, 2020, 2024 & 2031
2.2 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Segment by Type
2.2.1 Canagliflozin
2.2.2 Empagliflozin
2.2.3 Dapagliflozin
2.2.4 Ipragliflozin
2.2.5 Others
2.3 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Type
2.3.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Market Share by Type (2020-2025)
2.3.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sale Price by Type (2020-2025)
2.4 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Application
2.5.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sale Market Share by Application (2020-2025)
2.5.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Breakdown Data by Company
3.1.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Sales by Company (2020-2025)
3.1.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Market Share by Company (2020-2025)
3.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Revenue by Company (2020-2025)
3.2.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue by Company (2020-2025)
3.2.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue Market Share by Company (2020-2025)
3.3 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sale Price by Company
3.4 Key Manufacturers Sodium-dependent Glucose Co-transporter 2 (SGLT2) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Location Distribution
3.4.2 Players Sodium-dependent Glucose Co-transporter 2 (SGLT2) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Geographic Region
4.1 World Historic Sodium-dependent Glucose Co-transporter 2 (SGLT2) Market Size by Geographic Region (2020-2025)
4.1.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sodium-dependent Glucose Co-transporter 2 (SGLT2) Market Size by Country/Region (2020-2025)
4.2.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Growth
4.4 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Growth
4.5 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Growth
4.6 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales Growth
5 Americas
5.1 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Country
5.1.1 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Country (2020-2025)
5.1.2 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue by Country (2020-2025)
5.2 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Type (2020-2025)
5.3 Americas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Region
6.1.1 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Region (2020-2025)
6.1.2 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue by Region (2020-2025)
6.2 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Type (2020-2025)
6.3 APAC Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Country
7.1.1 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Country (2020-2025)
7.1.2 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue by Country (2020-2025)
7.2 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Type (2020-2025)
7.3 Europe Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Country
8.1.1 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) Revenue by Country (2020-2025)
8.2 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Type (2020-2025)
8.3 Middle East & Africa Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sodium-dependent Glucose Co-transporter 2 (SGLT2)
10.3 Manufacturing Process Analysis of Sodium-dependent Glucose Co-transporter 2 (SGLT2)
10.4 Industry Chain Structure of Sodium-dependent Glucose Co-transporter 2 (SGLT2)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Distributors
11.3 Sodium-dependent Glucose Co-transporter 2 (SGLT2) Customer
12 World Forecast Review for Sodium-dependent Glucose Co-transporter 2 (SGLT2) by Geographic Region
12.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Market Size Forecast by Region
12.1.1 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Forecast by Region (2026-2031)
12.1.2 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Forecast by Type (2026-2031)
12.7 Global Sodium-dependent Glucose Co-transporter 2 (SGLT2) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.1.3 Eli Lilly Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Janssen Pharmaceuticals
13.2.1 Janssen Pharmaceuticals Company Information
13.2.2 Janssen Pharmaceuticals Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.2.3 Janssen Pharmaceuticals Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Janssen Pharmaceuticals Main Business Overview
13.2.5 Janssen Pharmaceuticals Latest Developments
13.3 Bristol Myers Squibb
13.3.1 Bristol Myers Squibb Company Information
13.3.2 Bristol Myers Squibb Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.3.3 Bristol Myers Squibb Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bristol Myers Squibb Main Business Overview
13.3.5 Bristol Myers Squibb Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.5.3 AstraZeneca Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Astellas
13.6.1 Astellas Company Information
13.6.2 Astellas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.6.3 Astellas Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Astellas Main Business Overview
13.6.5 Astellas Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.7.3 Johnson & Johnson Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Sodium-dependent Glucose Co-transporter 2 (SGLT2) Product Portfolios and Specifications
13.8.3 Pfizer Sodium-dependent Glucose Co-transporter 2 (SGLT2) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂